NCT05714215

Brief Summary

The coma recovery scale-revised (CRS-R) is the recommended diagnostic scale for consciousness but it requires time, training, and provides total scores that do not always reflect the correct level of consciousness. Recently, a new short-term assessment tool for consciousness assessment has been validated, which could easily be implemented in daily practice to determine the level of consciousness in severely brain injured individuals: the simplified evaluation of consciousness disorders (SECONDs) .Its administration should be significantly shorter than CRS-R and accurate to allow monitoring of consciousness in the subacute / chronic phase. The SECONDs scale was constructed by selecting the items that, based on the latest scientific evidence, are most frequently associated with a minimally consciousness state. In fact, recent studies have shown that 5 items of the CRS-R allow to identify 99% of individuals with minimally consciousness state 1) reproducible movement on command, 2) visual pursuit 3) visual fixation 4) automatic motor response, and 5) localization to pain) 12. In addition, some changes have been introduced such as 1) the assessment of fixation and visual tracking through the use of the mirror 2) the use of autobiographical questions for the assessment of communication 3) the reduction of the number of orders on command to 2 of 3 instead of 3 out of 4 as in the CRS-R. All these changes have been made to minimize time for administration without compromising the accuracy of consciousness detection, to improve feasibility in clinical practice, and also to limit fatigue, which could produce better patient concentration and collaboration. The aim of the multicentre study is to carry out a cross-cultural translation of the SECONDs assessment scale into Italian and to perform a validation between operators of different professions of the Italian version. validation will be conducted on a group of patients with prolunged disorders of consciousness in the subacute phase admitted to two units of severe acquired brain injuries of the don Carlo Gnocchi Foundation of Florence and Sant'Angelo dei Lombardi, and in the chronic phase IRCCS foundation Carlo Besta neurological institute

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 28, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 19, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 6, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

February 21, 2023

Status Verified

January 1, 2023

Enrollment Period

8 months

First QC Date

January 19, 2023

Last Update Submit

February 17, 2023

Conditions

Keywords

Disorders of ConsciousnessScaleValidationdiagnosis

Outcome Measures

Primary Outcomes (2)

  • The concurrent validity of the transcultural adaptation of the SECONDs scale with the CRS-R (correlation coefficient for Spearman's ranks)

    The endpoint of the study is the creation of a valid and reliable transcultural adaptation of the SECONDs scale

    21 months

  • the indexes of agreement between inter and intra examiners (index K)

    The endpoint of the study is the creation of a valid and reliable transcultural adaptation of the SECONDs scale

    21 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

For the pilot intra and inter-rater validation study (Phase 2A), the enrollment of 10 consecutive patients (5 Florence, 2 Sant'Angelo and 3 Besta) is envisaged, subject to the signature of the informed consent of the legal representative. For the second phase of multicentre validation, the recruitment of 60 consecutive or distributed patients is foreseen, Florence: 28; Sant'Angelo: 10 and Istituto Besta: 22.

You may qualify if:

  • Diagnosis of severe acquired brain injury
  • Diagnosis of a disorder of consciousness
  • \> 28 days from the acute event
  • age\> 18 years
  • No history of neurological or psychiatric deficits
  • Mother tongue: Italian
  • Clinical stability (eg, absence of mechanical ventilation, sedation, infection, ensuing seizures).
  • Signature of the informed consent by the legal representative

You may not qualify if:

  • Appearance of a second brain event

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS-don Gnocchi Foundation

Florence, 50143, Italy

RECRUITING

Related Publications (2)

  • Aubinet C, Cassol H, Bodart O, Sanz LRD, Wannez S, Martial C, Thibaut A, Martens G, Carriere M, Gosseries O, Laureys S, Chatelle C. Simplified evaluation of CONsciousness disorders (SECONDs) in individuals with severe brain injury: A validation study. Ann Phys Rehabil Med. 2021 Sep;64(5):101432. doi: 10.1016/j.rehab.2020.09.001. Epub 2021 Jul 28.

    PMID: 32992025BACKGROUND
  • Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9. doi: 10.1016/j.apmr.2004.02.033.

    PMID: 15605342BACKGROUND

MeSH Terms

Conditions

Consciousness DisordersDisease

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersPathologic Processes

Study Officials

  • Bahia Hakiki, Dr

    IRCCS-Fondazione Don Gnocchi-Florence

    PRINCIPAL INVESTIGATOR
  • Bahia Hakiki, Dr

    IRCCS-Fondazione Don Gnocchi-Florence

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2023

First Posted

February 6, 2023

Study Start

October 28, 2021

Primary Completion

June 15, 2022

Study Completion

October 31, 2023

Last Updated

February 21, 2023

Record last verified: 2023-01

Locations